Overview

Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that persons with the particular cluster of symptoms that are due to supraesophageal reflux (SER) will have complete resolution of those symptoms with adequate acid suppression when a PPI is administered for 6 months.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
AstraZeneca
Treatments:
Esomeprazole
Proton Pump Inhibitors